Medtronic Plc Share Price Today
(NASDAQ: MDT)

Name: Medtronic Plc Share Price Today (NASDAQ: MDT) - Medtronic Plc Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Medtronic Plc share price is $89.94 & ₹7,800.14 as on 22 Feb 2025, 2.30 'hrs' IST

$89.94

▲

(2.27%)

Market is closed - opens 8 PM, 24 Feb 2025

View live Medtronic Plc share price in Dollar and Rupees. Guide to invest in Medtronic Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Medtronic Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Medtronic Plc share price movements

Today's Low: $87.74
Today's High: $90.82
$89.94
2.45%
Downside
Day's Volatility :3.39%
Upside
0.97%
52 Weeks Low: $75.96
52 Weeks High: $93.08
$89.94
15.54%
Downside
52 Weeks Volatility :18.39%
Upside
3.37%

Medtronic Plc (MDT) Returns

Period	Medtronic Plc	Sector (Health Care)	S&P500
3 Months	4.89%	1.6%	0.7%
6 Months	0.67%	-5.8%	6.7%
1 Year	7.49%	-1.0%	18.2%
3 Years	-15.02%	15.7%	42.3%

Medtronic Plc (MDT) Key Statistics

in dollars & INR

Previous Close	$87.94
Open	$87.64
Today's High	$90.82
Today's Low	$87.74
Market Capitalization	$112.9B
Today's Volume	$10.1M
52 Week High	$93.08
52 Week Low	$75.96
Revenue TTM	$33.2B
EBITDA	$9.5B
Earnings Per Share (EPS)	$3.28
PE Ratio	26.81
Dividend Yield	3.22%
Profit Margin	12.83%
Quarterly Earnings Growth YOY	0.02%
Return On Equity TTM	8.44%

How to invest in Medtronic Plc Stock (MDT) from India?

It is very easy for Indian residents to invest directly in Medtronic Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Medtronic Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Medtronic Plc or MDT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Medtronic Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Medtronic Plc shares which would translate to 0.010 fractional shares of Medtronic Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Medtronic Plc, in just a few clicks!

Returns in Medtronic Plc (MDT) for Indian investors in Rupees

The Medtronic Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Medtronic Plc investment value today

Current value as on today

₹1,12,143

Returns

₹12,143

(+12.14%)

Returns from Medtronic Plc Stock

₹7,494 (+7.49%)

Dollar Returns

₹4,649 (+4.65%)

Indian investors sentiment towards Medtronic Plc (MDT)

58.33%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Investment in Medtronic Plc Shares from India has grown by 58.33% over the past 30 days, indicating increased transactional activity.

30%

Period: Jan 24, 2025 to Feb 23, 2025. Change in 30 Days versus previous period

Search interest for Medtronic Plc Stock from India on INDmoney has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Indian Mutual Funds that invest in Medtronic Plc Stock (MDT Ticker)

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	1934	0.00	1.00%
Motilal Oswal S&P 500 Index Fund Direct Growth	11063	-230.88	0.22%
ICICI Prudential US Bluechip Equity Fund Direct Plan Growth	81546	-9711.31	1.93%

Global Institutional Holdings in Medtronic Plc

Vanguard Group Inc
9.69%
BlackRock Inc
8.68%
JPMorgan Chase & Co
4.74%
State Street Corp
4.74%
Capital Research Global Investors
2.59%
Geode Capital Management, LLC
2.07%

Analyst Recommendation on Medtronic Plc

Buy

51%Buy

43%Hold

5%Sell

Based on 37 Wall street analysts offering stock ratings for Medtronic Plc(by analysts ranked 0 to 5 stars)

Based on 37 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Medtronic Plc Stock (MDT)

What analysts predicted

Upside of 6.52%

Target:

$95.81

Current:

$89.94

Insights on Medtronic Plc Stock (Ticker Symbol: MDT)

Price Movement
In the last 3 months, MDT stock has moved up by 4.3%
Decreasing Revenue
Medtronic Plc has experienced a decline in revenue over the last two quarters. Revenue decreased from $8.40 billion to $8.29 billion, reflecting an average decrease of 1.3% per quarter.
Increasing Net Profit
Medtronic Plc has shown a strong profit trend over the last four quarters. The company's net profit has increased from $654.0 million to $1.29 billion, which represents an average growth of 19.0% each quarter.
MDT vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 56.0% return, outperforming this stock by 51.0%
MDT vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 139.1% return, outperforming this stock by 151.8%
Price to Sales
Medtronic Plc (MDT) has a Price-to-Sales Ratio of 3.5, meaning that investors are willing to pay $3.5 for every $1 of sales the company generates. In comparison, Boston Scientific Corp. has a higher Price-to-Sales Ratio of 9.2, indicating that investors value its sales more highly relative to Medtronic's sales.

MDT Medtronic Plc Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$30.6B	↑ 2.02%
Net Income	$4.6B	↑ 49.19%
Net Profit Margin	15.16%	↑ 4.8%

	FY20	Y/Y Change
Revenue	$28.9B	↓ 5.38%
Net Income	$4.8B	↑ 3.41%
Net Profit Margin	16.56%	↑ 1.4%

	FY21	Y/Y Change
Revenue	$30.1B	↑ 4.16%
Net Income	$3.6B	↓ 24.7%
Net Profit Margin	11.97%	↓ 4.59%

	FY22	Y/Y Change
Revenue	$31.7B	↑ 5.21%
Net Income	$5.0B	↑ 39.74%
Net Profit Margin	15.9%	↑ 3.93%

	FY23	Y/Y Change
Revenue	$31.2B	↓ 1.45%
Net Income	$3.8B	↓ 25.42%
Net Profit Margin	12.03%	↓ 3.87%

	FY24	Y/Y Change
Revenue	$32.4B	↑ 3.64%
Net Income	$3.7B	↓ 2.18%
Net Profit Margin	11.36%	↓ 0.67%

	Q4 FY23	Q/Q Change
Revenue	$8.0B	↑ 3.66%
Net Income	$909.0M	↑ 14.92%
Net Profit Margin	11.39%	↑ 1.12%

	Q1 FY24	Q/Q Change
Revenue	$8.1B	↑ 1.32%
Net Income	$1.3B	↑ 45.43%
Net Profit Margin	16.34%	↑ 4.95%

	Q2 FY24	Q/Q Change
Revenue	$8.6B	↑ 6.18%
Net Income	$654.0M	↓ 50.53%
Net Profit Margin	7.61%	↓ 8.73%

	Q3 FY24	Q/Q Change
Revenue	$7.9B	↓ 7.85%
Net Income	$1.0B	↑ 59.33%
Net Profit Margin	13.16%	↑ 5.55%

	Q4 FY24	Q/Q Change
Revenue	$8.4B	↑ 6.17%
Net Income	$1.3B	↑ 21.88%
Net Profit Margin	15.11%	↑ 1.95%

	Q1 FY25	Q/Q Change
Revenue	$8.3B	↓ 1.32%
Net Income	$1.3B	↑ 1.89%
Net Profit Margin	15.61%	↑ 0.5%

	FY19	Y/Y Change
Profit	$21.4B	↑ 2.41%

	FY20	Y/Y Change
Profit	$19.5B	↓ 8.94%

	FY21	Y/Y Change
Profit	$19.6B	↑ 0.74%

	FY22	Y/Y Change
Profit	$21.5B	↑ 9.71%

	FY23	Y/Y Change
Profit	$20.5B	↓ 4.8%

	FY24	Y/Y Change
Profit	$21.1B	↑ 3.12%

	Q4 FY23	Q/Q Change
Profit	$5.2B	↑ 2.94%

	Q1 FY24	Q/Q Change
Profit	$5.3B	↑ 1.61%

	Q2 FY24	Q/Q Change
Profit	$5.2B	↓ 2.07%

	Q3 FY24	Q/Q Change
Profit	$4.7B	↓ 9.33%

	Q4 FY24	Q/Q Change
Profit	$5.5B	↑ 15.81%

	Q1 FY25	Q/Q Change
Profit	$2.1B	↓ 60.73%

	FY19	Y/Y Change
Operating Cash Flow	$7.0B	↑ 49.59%
Investing Cash Flow	$-774.0M	↓ 113.21%
Financing Cash Flow	$-5.4B	↓ 54.57%

	FY20	Y/Y Change
Operating Cash Flow	$7.2B	↑ 3.24%
Investing Cash Flow	$-3.2B	↑ 313.82%
Financing Cash Flow	$-4.2B	↓ 22.7%

	FY21	Y/Y Change
Operating Cash Flow	$6.2B	↓ 13.74%
Investing Cash Flow	$-2.9B	↓ 10.52%
Financing Cash Flow	$-4.1B	↓ 1.48%

	FY22	Y/Y Change
Operating Cash Flow	$7.3B	↑ 17.72%
Investing Cash Flow	$-1.7B	↓ 42.11%
Financing Cash Flow	$-5.3B	↑ 29.01%

	FY23	Y/Y Change
Operating Cash Flow	$6.0B	↓ 17.79%
Investing Cash Flow	$-3.5B	↑ 110.55%
Financing Cash Flow	$-5.0B	↓ 7.05%

	Q4 FY23	Q/Q Change
Operating Cash Flow	$661.0M	↓ 24.46%
Investing Cash Flow	$-424.0M	↓ 21.34%
Financing Cash Flow	$-90.0M	↓ 82.04%

Medtronic Plc Technicals Summary

Sell

Neutral

Buy

Medtronic Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Medtronic Plc (MDT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Medtronic Plc	-0.28%	0.67%	7.49%	-15.02%	-15.27%
Edwards Lifesciences Corp.	6.25%	6.62%	-14.92%	-35.15%	-0.76%
Boston Scientific Corp.	2.5%	31.48%	56.73%	131.69%	165.27%
Stryker Corporation	-2.92%	8.04%	8.6%	44.02%	89.81%
Abbott Laboratories	7.91%	19.72%	13.67%	10.22%	65.83%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Medtronic Plc	26.81	26.81	1.48	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.32	31.32	5.83	2.45	0.17	0.11	NA	16.18
Boston Scientific Corp.	84.29	84.29	1.88	2.86	0.09	0.05	NA	14.76
Stryker Corporation	49.73	49.73	2.71	13.51	0.15	0.07	0.01	54.1
Abbott Laboratories	17.43	17.43	2.38	5.15	0.34	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Medtronic Plc	Buy	$112.9B	-15.27%	26.81	12.83%
Edwards Lifesciences Corp.	Buy	$43.2B	-0.76%	31.32	76.75%
Boston Scientific Corp.	Buy	$155.5B	165.27%	84.29	11.07%
Stryker Corporation	Buy	$147.4B	89.81%	49.73	13.25%
Abbott Laboratories	Buy	$231.0B	65.83%	17.43	31.95%

Medtronic Plc Dividend announcements

Medtronic Plc Dividends December, 2024
In the quarter ending December,2024. Medtronic Plc has declared dividend of $0.70
Read More

About Medtronic Plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Organization	Medtronic Plc
Employees	95000
CEO	Mr. Geoffrey Straub Martha
Industry	Health Technology

Management People of Medtronic Plc

Name	Title
Mr. Geoffrey Straub Martha	Chairman of the Board & CEO
Mr. Sean M. Salmon	Executive VP & President of Cardiovascular Portfolio
Mr. Brett A. Wall	Executive VP & President of Neuroscience Portfolio
Mr. Gregory L. Smith	Executive Vice President of Global Operations & Supply Chain
Gary Corona	Senior Vice President of Global Financial Planning and Analysis & Interim CFO
Mr. Mark Ploof	Senior Vice President of Global Operations and Business Services
Ms. Jennifer M. Kirk	Senior VP, Global Controller & Chief Accounting Officer
Dr. Kenneth E. Washington Ph.D.	Senior VP and Chief Technology & Innovation Officer
Dr. Laura Mauri M.D., M.Sc.	Senior VP and Chief Scientific & Medical Officer
Mr. Ryan Weispfenning	VP & Head of Investor Relations

Important FAQs about investing in MDT Stock from India :

What is Medtronic Plc share price today?

Medtronic Plc share price today stands at $89.94, Open: $87.64 ; Previous Close: $87.94 ; High: $90.82 ; Low: $87.74 ; 52 Week High: $93.08 ; 52 Week Low: $75.96.

The stock opens at $87.64, after a previous close of $87.94. The stock reached a daily high of $90.82 and a low of $87.74, with a 52-week high of $93.08 and a 52-week low of $75.96.

Can Indians buy Medtronic Plc shares?

Yes, Indians can invest in the Medtronic Plc (MDT) from India.

With INDmoney, you can buy Medtronic Plc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Medtronic Plc at zero transaction cost.

How can I buy Medtronic Plc shares from India?

It is very easy to buy Medtronic Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Medtronic Plc (MDT) be purchased?

Yes, you can buy fractional shares of Medtronic Plc with INDmoney app.

What are the documents required to start investing in Medtronic Plc stocks?

To start investing in Medtronic Plc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.